APA (7th ed.) Citation

BS, S., LV, M., M, W., I, G., L, M., TL, G., . . . JT, B. (2021). Evaluating the clinical utility of early exome sequencing in diverse pediatric outpatient populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 study: A randomized controlled trial. Trials, 22(1), 395. https://doi.org/10.1186/s13063-021-05341-2

Chicago Style (17th ed.) Citation

BS, Staley, et al. "Evaluating the Clinical Utility of Early Exome Sequencing in Diverse Pediatric Outpatient Populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 Study: A Randomized Controlled Trial." Trials 22, no. 1 (2021): 395. https://doi.org/10.1186/s13063-021-05341-2.

MLA (9th ed.) Citation

BS, Staley, et al. "Evaluating the Clinical Utility of Early Exome Sequencing in Diverse Pediatric Outpatient Populations in the North Carolina Clinical Genomic Evaluation of Next-generation Exome Sequencing (NCGENES) 2 Study: A Randomized Controlled Trial." Trials, vol. 22, no. 1, 2021, p. 395, https://doi.org/10.1186/s13063-021-05341-2.